WHO announces successful Phase II trial of new meningitis vaccine
-
Last Update: 2020-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
the World Health Organization announced on thea successful second phase of a new, high-cost meningitis vaccine in Africa
,a successful second phase of the trial, which could signal the possibility of providing long-term protection against meningitis that is endemic in AfricaThe WORLD Health Organization on the 8th released thechildren in Western Africathe effectiveness of the new meningitis vaccine dataThe results showed that, thethe effectiveness of the new vaccine, which costs 40 cents per dose, to protectchildren in Africa
and their communities, more than any vaccine available on the market in the regionAccording to reports, the new vaccine can block the deadly group A meningitis Nisser infection, and will extend the protection to unvaccinated people, to achieve the "group immunization" effectPreliminary findings from phase II trials suggest that the new vaccine could significantly reduce the incidence of meningitis2
1 country in sub-Saharan Africa"This important study raises real hope that through immunization, the lives of thousands of children and adolescents will be saved and that mass suffering, , disease
and socio-economic chaos will be averted," WHO Director-General Margaret Chan said in a statement It is reported that , is currently the of follow-up trials, to finally confirm the effectiveness of the new vaccine (
reprinted from "Xinhuanet")
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
